Sysmex Corp. will increase its diagnostic reagent supply in the United States in order to meet the increasing demand for diagnostic reagents that will result from an increasing share of the U.S.

TOKYO & KOBE, Japan--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have signed an agreement for ...

TOKYO & KOBE, Japan--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announce that ...

CHICAGO, Jan. 15, 2025 /PRNewswire/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, today ...

Sysmex America has announced that as part of its initiative to offer cutting edge clinical laboratory products, the introduction of CyFlow Antibodies; a comprehensive portfolio of Analyte Specific ...

"Sysmex's hemostasis solutions bring together advanced technology, trusted reagents and award-winning service to provide laboratories with reliable results for diagnosing patients suffering from ...

MUNDELEIN, Ill., April 19, 2011 /PRNewswire/ -- Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, announced today an amended distributorship agreement ...

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato ...

Sysmex Corporation and Eisai Co., Ltd. have announced that the two companies have entered into a comprehensive non-exclusive collaboration agreement aimed at the creation of new diagnostics in the ...

CHICAGO, May 28, 2026 /PRNewswire/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, has introduced ...